Literature DB >> 24019084

Endothelial and platelet function in children with previous Kawasaki disease.

Marianna Laurito1, Alessandra Stazi1, Angelica B Delogu2, Maria Milo1, Irma Battipaglia1, Giancarla Scalone1, Fabio Infusino1, Angelo Villano1, Giulio Russo1, Rossella Iannotta2, Annalisa Saracino2, Rossella Parrinello1, Stefano Figliozzi1, Alfonso Sestito1, Costantino Romagnoli2, Gaetano A Lanza3, Filippo Crea1.   

Abstract

We investigated whether children with a previous Kawasaki disease (KD) have evidence of abnormal vascular and/or platelet function. We included 14 patients with previous KD and 14 matched controls. We assessed endothelial function by flow-mediated dilation (FMD), carotid intima-media thickness (cIMT), coronary microvascular function by coronary blood flow response (CBFR) to cold pressor test, and platelet reactivity by measuring monocyte-platelet aggregates (MPAs) and CD41-platelet expression by flow cytometry. No differences were found between the groups in FMD, cIMT, or CBFR to cold pressor test. The MPAs were similar in patients with KD and controls. CD41-platelet expression, however, was significantly increased in patients with KD compared with controls, both at rest (14.3 ± 1.9 vs 12.4 ± 1.9 mean fluorescence intensity [mfi], P = .01) and after adenosine diphosphate stimulation (19.3 ± 1.3 vs 17 ± 1.7 mfi, P < .001). In conclusion, children with a previous episode of KD showed increased platelet activation, compared with healthy participants despite no apparent vascular abnormality at follow-up.
© The Author(s) 2013.

Entities:  

Keywords:  Kawasaki disease; carotid intima-medial thickness; endothelial function; platelet function

Mesh:

Year:  2013        PMID: 24019084     DOI: 10.1177/0003319713502392

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  8 in total

Review 1.  Meta-analysis of risk factors associated with atherosclerosis in patients with Kawasaki disease.

Authors:  Han Zhang; Ming-Guo Xu; Li-Jian Xie; Min Huang; Jie Shen; Ting-Ting Xiao
Journal:  World J Pediatr       Date:  2016-06-29       Impact factor: 2.764

Review 2.  Platelet Activation Dynamics in Kawasaki Disease- Revisited.

Authors:  Pandiarajan Vignesh; Surjit Singh
Journal:  Indian J Pediatr       Date:  2019-02-11       Impact factor: 1.967

3.  Association between adropin and coronary artery lesions in children with Kawasaki disease.

Authors:  Maoling Yang; Qiongfei Pei; Jing Zhang; Haobo Weng; Fengchuan Jing; Qijian Yi
Journal:  Eur J Pediatr       Date:  2021-03-13       Impact factor: 3.183

Review 4.  Peripheral Endothelial (Dys)Function, Arterial Stiffness and Carotid Intima-Media Thickness in Patients after Kawasaki Disease: A Systematic Review and Meta-Analyses.

Authors:  Sanne M Dietz; Carline E A Tacke; Barbara A Hutten; Taco W Kuijpers
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

5.  The Usefulness of Platelet-derived Microparticle as Biomarker of Antiplatelet Therapy in Kawasaki Disease.

Authors:  Hyun Jung Kim; Eun Hye Choi; Yeon Jung Lim; Hong Ryang Kil
Journal:  J Korean Med Sci       Date:  2017-07       Impact factor: 2.153

6.  Monocyte platelet aggregates in children with Kawasaki disease- a preliminary study from a tertiary care centre in North-West India.

Authors:  Pandiarajan Vignesh; Amit Rawat; Jitendra Kumar Shandilya; Man Updesh Singh Sachdeva; Jasmina Ahluwalia; Surjit Singh
Journal:  Pediatr Rheumatol Online J       Date:  2021-03-12       Impact factor: 3.054

Review 7.  An Update on Cardiovascular Risk Factors After Kawasaki Disease.

Authors:  Yuan-Yuan Zeng; Min Zhang; Syeun Ko; Feng Chen
Journal:  Front Cardiovasc Med       Date:  2021-04-16

8.  The Platelet microRNA Profile of Kawasaki Disease: Identification of Novel Diagnostic Biomarkers.

Authors:  Qianqian Ning; Liqin Chen; Sirui Song; Hong Zhang; Kangping Xu; Jia Liu; Yiwen Zhou; Chenyang Zang; Guang Li; Feng Chen; Jia Jia; Guohui Ding; Min Huang
Journal:  Biomed Res Int       Date:  2020-07-17       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.